“…Whereas several studies have demonstrated that patients with ACA have poorer prognosis than those with SCC [3][4][5][6][7][8][9][10]27,28,32] this study shows no difference in the therapeutic response and death rate at the end of the first course of cancer-directed therapy, which is in accordance with the findings of other studies that indicates similar recurrence rate [33][34] and survival [4,5,35] between both histologic types of cervical cancer. Considering patients with locally advanced and advanced disease, FIGO stage ≥ IIB, radiotherapy alone was the treatment strategy for 43.9% of the ACA patients and 52% of the SCC patients, and an inadequate response was observed in 33.3% and 31.6% of them, respectively.…”